Company · CIK 0001653477 · SIC 2800 — Chemicals & Allied Products · NYSE
Ingevity Corp · NGVT
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 14, 2026 SForm 4 → | Aug 18, 5:14 pm EDT | David H LiPresident & CEO, Director | 10,092 | $75.77 | $764,673 | 120,544 | −7.73% | 10b5-1 |
| Aug 12, 2026 SForm 4 → | Aug 14, 5:06 pm EDT | David H LiPresident & CEO, Director | 10,000 | $76.18 | $761,750 | 130,636 | −7.11% | 10b5-1 |
| Aug 10, 2026 FForm 4 → | Aug 11, 4:45 pm EDT | Phillip John PlattSVP, Chief Financial Officer | 1,698 | $77.04 | $130,814 | 26,641 | — | |
| Aug 3, 2026 SForm 4 → | Aug 4, 5:14 pm EDT | Ryan C. FisherSVP, Gen. Counsel & Secretary | 2,709 | $73.72 | $199,698 | 15,722 | −14.7% | |
| Jul 24, 2026 FForm 4 → | Jul 28, 4:48 pm EDT | Phillip John PlattSVP, Chief Financial Officer | 3,294 | $73.26 | $241,318 | 28,339 | — | |
| Jul 6, 2026 FForm 4 → | Jul 8, 5:07 pm EDT | Ryan C. FisherSVP, Gen. Counsel & Secretary | 168 | $73.86 | $12,408 | 18,431 | — | |
| Jul 1, 2026 AForm 4 → | Jul 2, 4:23 pm EDT | J Kevin WillisDirector | 397 | $72.58 | $28,814 | 11,478 | — | |
| Jul 1, 2026 AForm 4 → | Jul 2, 4:21 pm EDT | Francis David SegalDirector | 328 | $72.58 | $23,806 | 8,612 | — |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.